Intracranial neuromodulation is an evolving therapy for patients with drug-resistant epilepsy (DRE). Deep brain stimulation (DBS) is now available as a therapy for patients with DRE and focal-onset seizures in select health care systems; however, there remains a substantial need of efficacy data before DBS can be more widely adopted into routine clinical practice. This review and commentary focuses on a particular shifting paradigm: DBS as a therapy for children with generalized-onset seizures.
Keywords: Children; Deep brain stimulation; Epilepsy; Generalized epilepsy; Neuromodulation; Pediatrics.
Copyright © 2023 Elsevier Inc. All rights reserved.